The ‘Yale Report’ Against the Cass Review: Science or a Legal Brief for the Court?

Since the publication of the Cass Review in 2024 — the four-year British investigation into the evidence base for puberty blockers and cross-sex hormones for young people with gender dysphoria — advocates of the gender-affirmative model have sought to undermine the report. The most frequently cited weapon is a paper by American pediatrician Meredithe McNamara and co-authors, including prominent gender-affirmative physicians such as Johanna Olson-Kennedy and Jack Turban. Their paper claims that the Cass Review “repeatedly misuses data” and violates its own evidentiary standards — a report that stands in the same tradition as the Dutch Dutch Protocol, which served for decades as the foundation for Western gender care and is now itself facing the same methodological criticism. The problem: that claim has never been peer-reviewed, and the paper was written for a purpose other than advancing science.

What exactly is being claimed, and by whom?

The paper appeared on the website of the so-called “Integrity Project,” housed at Yale Law School. That provenance gave the paper international credibility: media outlets and activist organizations soon began referring to it as the “Yale Report,” as though the university itself had endorsed its contents. That is not what happened. Yale Law School did not publish the paper as its own scholarly research, but merely provided the platform on which McNamara and her co-authors — most of whom are not affiliated with Yale — posted their text. An analysis of the “Yale” claim by the Society for Evidence-Based Gender Medicine (SEGM) explains how this arrangement works and why the suggestion of university approval is misleading.

No peer review, but a role in the courtroom

The most striking fact is not the content of the criticism, but how it has been used. McNamara and several co-authors served as paid expert witnesses in more than a dozen U.S. lawsuits concerning gender care for minors, and submitted an almost identical version of their paper as an amicus brief to the U.S. Supreme Court in the high-profile case United States v. Skrmetti. In other words: the same document functioned simultaneously as supposedly independent scholarly criticism and as a legal brief by authors who had a financial interest in persuading judges to take the Cass Review less seriously. Such a dual role — author of the “scholarly” rebuttal and paid witness in the cases that stood to benefit from it — would have been flagged and weighed as an obvious conflict of interest in a peer-reviewed journal. That safeguard is absent from an unreviewed publication on a university platform.

What British clinicians put forward in response

A recent counter-analysis by several leading British clinicians — directly involved in or familiar with the development of the Cass Review — concludes that the McNamara paper is not a serious scholarly effort, but a document written primarily to influence U.S. litigation, packaged as methodological criticism. They point out that the paper cites selectively, fails to discuss the original systematic reviews underpinning the Cass Review in their full methodological context, and draws conclusions that go beyond what the data support. That is a serious accusation, and readers must weigh the underlying sources for themselves — but the pattern they expose, involving presentation and interests, is itself verifiable and is documented below through the sources.

The BMA motion: how the Yale label influenced policy

The alleged Yale provenance of the McNamara paper played a direct role when the British Medical Association (BMA) adopted a motion in 2024 calling the Cass Review “unsubstantiated” and urging a reconsideration of its implementation. At the time, medical organizations and commentators pointed out that the motion relied heavily on the authority attributed to the “Yale Report” — without the underlying claims themselves having been independently examined. The BMA later partially revised that position, in part because it became clearer how the paper had been produced and what interests the authors had in ongoing U.S. litigation.

A broader pattern: consensus based on authority, not evidence

This episode does not stand alone. Our partner site wpath.nl previously documented how a Harvard legal scholar concluded that WPATH’s own “medical consensus” rests largely on politics rather than evidence. The mechanism is similar: an authoritative institution — a university, a professional association — is used to lend authority to a claim that would not carry the same weight on its own. For readers seeking to follow the science and debate surrounding gender care, this is an important signal: the question “who published this?” is not the same as the question “has this been reviewed?” Our earlier article on the Dutch quality standard for transgender care showed a similar pattern: authoritative institutions endorsing claims without explicitly weighing the underlying conflicts of interest.

Source versus interpretation

It is important to keep one distinction clear: the fact that the McNamara paper was not peer-reviewed and was used by its authors in litigation does not, in itself, definitively establish that every individual claim in it is false. It does mean that the paper does not deserve the status suggested by the label “Yale Report,” and that the authors’ dual role — scientific critic and paid litigant — warrants caution from anyone citing the paper as neutral scholarship. That interpretation is ours as editors; the facts about its provenance, funding, and the lawsuits are supported by sources above.

Sources

Society for Evidence-Based Gender Medicine (SEGM), “The Cass Review, the ‘Yale’ Report, and the Importance of Keeping Special Interests at Bay”, 2026. segm.org/Cass_Integrity_Project_Yale

Yale Law School, “White Paper Addresses Key Issues in Legal Battles over Gender-Affirming Health Care”. law.yale.edu — Integrity Project white paper

Erin Reed, “British Medical Association Calls Cass Review ‘Unsubstantiated,’ Passes Resolution Against Implementation”, Erin In The Morning, 2024. erininthemorning.com — BMA resolution

Wpath.nl, “Harvard legal scholar: WPATH built its ‘medical consensus’ on politics, not evidence”, 2026. wpath.nl/artikelen/harvard-jlpp-facade-medical-consensus-wpath